Patents-Review.com
ClassID:

94147 ⎘

C07D211/10 - CPC Classification

Classification description:

Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms

Sub-classes:
Recent Application in this class:
#1
20250305953
2025-10-02

LIGHT-EMITTING RADICAL CATION PROBE IN SITU GENERATED BY ACID INDUCTION, AND PREPARATION THEREFOR AND APPLICATION THEREOF

 #2
20250250227
2025-08-07

AMINO LIPID COMPOUND, PREPARATION METHOD THEREFOR, COMPOSITION THEREOF AND USE THEREOF

 #3
20230142654
2023-05-11

NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF

 #4
20220356155
2022-11-10

FUEL HIGH TEMPERATURE ANTIOXIDANT ADDITIVE

 #5
20220298155
2022-09-22

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

 #6
20220024891
2022-01-27

THERAPEUTICS TARGETING MUTANT ADENOMATOUS POLYPOSIS COLI (APC) FOR THE TREATMENT OF CANCER

 #7
20200308163
2020-10-01

Compounds and compositions as modulators of TLR signaling

 #8
20200277255
2020-09-03

Biguanide compound and use thereof

 #9
20200199160
2020-06-25

STAT3 dimerization inhibitors

 #10
20180354901
2018-12-13

Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use

 #11
20180342769
2018-11-29

ELECTROLYTIC SOLUTION, METHOD FOR PREPARING ESTER COMPOUND CONTAINED THEREIN AND LITHIUM SECONDARY CELL

 #12
20180222894
2018-08-09

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

 #13
20180179235
2018-06-28

STAT3 dimerization inhibitors

 #14
20180079712
2018-03-22

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

 #15
20180072660
2018-03-15

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

 #16
20180044283
2018-02-15

Biguanide compound and use thereof

 #17
20170114050
2017-04-27

N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and their use thereof

 #18
20160318866
2016-11-03

SUBSTITUTED BIPIPERIDINYL DERIVATIVES

 #19
20160215000
2016-07-28

Production and use of zinc amides

 #20
20150368196
2015-12-24

Antiviral compounds

 #21
20150306082
2015-10-29

Solenopsin and derivatives, therapeutic compositions; and methods related thereto

 #22
20150259366
2015-09-17

STAT3 dimerization inhibitors

 #23
20140335079
2014-11-13

SOLENOPSIN AND DERIVATIVES, THERAPEUTIC COMPOSITIONS, AND METHODS RELATED THERETO

 #24
20130203738
2013-08-08

Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)

 #25
20110288296
2011-11-24

Production and use of zinc amides

 #26
20110281850
2011-11-17

INTRACELLULAR KINASE INHIBITORS

 #27
20110130568
2011-06-02

Acylsulfonamides and processes for producing the same

 #28
20100087437
2010-04-08

Potassium channel blockers

 #29
20100069630
2010-03-18

Naphthalenyloxypropenyl derivatives having inhibitory activity against histone deacetylase and pharmaceutical composition comprising the same

 #30
20090012074
2009-01-08

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

 #31
20070293499
2007-12-20

Intracellular kinase inhibitors

 #32
20070219176
2007-09-20

Viral polymerase inhibitors

 #33
20060287303
2006-12-21

Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

 #34
20060178366
2006-08-10

Compounds for the treatment of inflammatory disorders